Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
4
×
new york top stories
biotech
boston blog main
boston top stories
fda
new york blog main
san francisco top stories
san diego blog main
san diego top stories
san francisco blog main
abbvie
acorda therapeutics
aimmune therapeutics
akcea therapeutics
allergy
alnylam pharmaceuticals
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
barry greene
billy dunn
biogen
boston
boston university
boulder/denver blog main
boulder/denver top stories
dalfampridine
dan ollendorf
daniel edelman
detroit blog main
detroit top stories
drug prices
drug pricing
drugs
What
fda
friday
4
×
approved
drug
patients
late
medicine
new
oral
therapy
time
acorda
agency
ago
aimmune
allergy
alnylam
approval
approve
atrophy
awaits
awarded
biological
cope
crossed
daily
decades
decision
developed
discovered
disease
episodes
evrysdi
fingers
gets
green
help
historic
home
immunotherapy
Language
unset
Current search:
friday
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision